End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says | MT |
Apr. 18 | UK Regulator to Consider Undertakings for Theramex-Viatris Deal | MT |
Financials (USD)
Sales 2024 * | 15.22B | Sales 2025 * | 14.98B | Capitalization | 13.74B |
---|---|---|---|---|---|
Net income 2024 * | 1.88B | Net income 2025 * | 989M | EV / Sales 2024 * | 1.78 x |
Net Debt 2024 * | 13.28B | Net Debt 2025 * | 11.4B | EV / Sales 2025 * | 1.68 x |
P/E ratio 2024 * |
7.99
x | P/E ratio 2025 * |
13.3
x | Employees | - |
Yield 2024 * |
4.34% | Yield 2025 * |
4.52% | Free-Float | 97.9% |
Latest transcript on Mylan Inc
Managers | Title | Age | Since |
---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 61 | 22-12-28 |
Abhijit Barve
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | 20-11-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Melina Higgins
CHM | Chairman | 56 | 20-11-15 |
Mark Parrish
BRD | Director/Board Member | 68 | 20-11-15 |
Harry Korman
BRD | Director/Board Member | 66 | 20-11-15 |
1st Jan change | Capi. | |
---|---|---|
+25.62% | 661B | |
+26.74% | 566B | |
-6.64% | 352B | |
+19.92% | 332B | |
+3.02% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.30% | 145B |